Understanding Adenosine Deaminase Deficiency

Adenosine deaminase (ADA) deficiency is a genetic disorder that affects the immune system. It is a form of severe combined immunodeficiency (SCID).

The disorder is caused by a problem with the gene that makes the enzyme adenosine deaminase (ADA). This enzyme is crucial for breaking down a substance called deoxyadenosine. Without functional ADA, deoxyadenosine builds up in the body, especially in immune cells (like lymphocytes), becoming toxic and destroying them.

Let's look at how changes in the gene, known as mutations, can lead to this deficiency.

Genetic Basis of ADA Deficiency

The gene responsible for producing the adenosine deaminase enzyme is located on chromosome 20. Like any other gene, it contains the instructions for building a specific protein (the ADA enzyme in this case). For the enzyme to function correctly, the gene's DNA sequence must be accurate.

How Gene Mutations Cause ADA Deficiency

Mutations are changes in the DNA sequence of a gene. These changes can affect how much enzyme is produced or whether the enzyme works correctly. Different types of mutations can occur:

• Point mutations: A change in a single DNA base.
• Insertions: Adding extra DNA bases.
• Deletions: Removing DNA bases.
• Duplications: Copying a section of DNA.
• Translocations: Moving a segment of DNA from one chromosome to another.
• Inversions: Reversing a segment of DNA within a chromosome.

Adenosine Deaminase Deficiency and Deletion Mutation

While ADA deficiency can be caused by various types of mutations in the ADA gene, including point mutations, a significant cause, especially for severe forms, is a specific type of mutation called a deletion.

• A deletion occurs when a segment of DNA is removed from the gene.
• If this deletion is large enough, or if it occurs in a critical part of the gene, it can result in the gene being unable to produce any functional adenosine deaminase enzyme at all.
• Without the ADA enzyme, the toxic substance deoxyadenosine builds up, leading to the destruction of immune cells and causing the severe immune deficiency seen in ADA deficiency.
• Smaller deletions or deletions in less critical areas might lead to reduced enzyme function or production, resulting in less severe forms of the disorder. However, total or significant loss of function is often due to substantial deletions or critical point mutations/small deletions.

The question specifically asks what type of gene change causes ADA deficiency, and among the options provided, deletion is a well-established genetic mechanism leading to the loss of functional adenosine deaminase.

Let's briefly consider why the other options are generally not the primary cause for classic severe ADA deficiency:

• Duplication: Copying a gene segment usually wouldn't eliminate enzyme function; it might even increase it or have little effect, depending on the location.
• Translocation: Moving a gene can disrupt its function if it breaks the gene or moves it to a location where its regulation is disturbed. However, a simple translocation doesn't inherently mean the gene product will be absent or non-functional in the way a deletion often does.
• Inversion: Reversing a gene segment can disrupt function if the break points are within the gene sequence or if it affects regulatory regions. Like translocation, it's a possibility for gene disruption but deletion is a direct loss of genetic material.

Given the options, deletion is the most direct type of mutation listed that typically results in the complete or near-complete loss of the gene product (adenosine deaminase enzyme), which is the hallmark of severe ADA deficiency.

Therefore, adenosine deaminase deficiency is caused by gene mutations, prominently including deletions, which lead to the absence or severe reduction of the functional ADA enzyme.

Revision Table: Gene Mutations

Understanding different types of gene mutations is key in genetics.

• Deletion: Loss of genetic material. Can cause severe loss of protein function.
• Insertion: Gain of genetic material. Can shift reading frame (frameshift) or disrupt gene.
• Point Mutation: Single base change. Can be silent, missense, or nonsense, affecting protein function to varying degrees.
• Duplication: Copying of genetic material. Can alter gene dosage or lead to fusions.
• Inversion: Segment flipped around. Can disrupt genes at breakpoints or affect regulation.
• Translocation: Segment moved to another chromosome. Can disrupt genes at breakpoints or create fusion genes.

Additional Information: Adenosine Deaminase Deficiency

Adenosine deaminase deficiency is a serious genetic disorder.

• It impairs the development and function of T lymphocytes, B lymphocytes, and natural killer (NK) cells, severely compromising the immune system.
• Infants with severe ADA deficiency are highly susceptible to recurrent and overwhelming infections.
• Early diagnosis and treatment are critical. Treatments include enzyme replacement therapy, hematopoietic stem cell transplantation (bone marrow transplant), and gene therapy.
• Gene therapy for ADA deficiency was one of the first successful examples of gene therapy for a genetic disorder. It involves introducing a functional copy of the ADA gene into the patient's own cells.

Studying the specific genetic mutations, like deletions, helps researchers understand the disease mechanisms and develop targeted therapies.